+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pets Anti-infective Drugs Market - Global Forecast 2025-2030- Product Image
Pets Anti-infective Drugs Market - Global Forecast 2025-2030- Product Image
Sale

Pets Anti-infective Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6123178
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global pets anti-infective therapeutics market is entering a transformative phase, driven by technological advancements, evolving stakeholder needs, and regulatory shifts impacting product development and commercialization.

Market Snapshot: Pets Anti-Infective Therapeutics

The market for pets anti-infective therapeutics is witnessing robust expansion alongside rapid innovation in drug discovery platforms and delivery mechanisms. Increased awareness of antimicrobial resistance, emergence of novel pathogens, and shifts in companion animal demographics are reshaping therapeutic priorities and investment strategies. Market participants are focusing on developing therapies that address bacterial, fungal, parasitic, and viral infections with improved safety, efficacy, and compliance profiles to meet the demands of a dynamic veterinary healthcare environment.

Scope & Segmentation

This report delivers a granular analysis of the pets anti-infective market through comprehensive segment coverage and geographic breakdowns. Key segmentation parameters include:

  • Drug Classes: Antibiotics (aminoglycosides, beta-lactams, macrolides, tetracyclines), Antifungals (azoles, polyenes), Antiparasitics (anticoccidials, endectocides), and Antivirals (nucleoside analogues).
  • Animal Types: Cats, dogs, horses, and small mammals (rabbits, rodents).
  • Distribution Channels: Online retailers, retail pharmacies, veterinary hospitals, and veterinary pharmacies.
  • Routes of Administration: Oral, parenteral (intramuscular, intravenous, subcutaneous), and topical.
  • Regions: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Companies Profiled: Zoetis Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim Animal Health GmbH, Ceva Santé Animale SA, Virbac SA, Vetoquinol SA, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Neogen Corporation.

Advancements in nanotechnology, biomaterial-based delivery, and digital diagnostics have contributed to the evolution of targeted, long-acting therapies. These innovations focus on improved compliance, better clinical outcomes, and enhanced supply chain resilience.

Key Takeaways

  • Veterinary care stakeholders are navigating heightened regulatory scrutiny and a complex risk-benefit landscape where safety and efficacy must be aligned with cost efficiency and compliance.
  • Digital transformation—including telemedicine and artificial intelligence-powered diagnostics—enables earlier detection, remote monitoring, and accelerated response to emerging infectious threats.
  • Rising antimicrobial resistance is prompting renewed investment in stewardship programs, precision dosing, and novel therapeutic combinations to maintain clinical effectiveness.
  • Product positioning and clinical support need to be adapted to the unique physiological needs of different animal types and compliance requirements of end users.
  • Collaborative industry frameworks, including academic partnerships and open innovation ecosystems, support R&D synergy and break down traditional sector silos.
  • Regional variations in regulatory stringency and market access call for localized engagement, agile supply chains, and tailored product portfolios.

Tariff Impact on Supply Chain Dynamics

Recent United States tariff adjustments have introduced broad supply chain challenges for anti-infective product manufacturers. Increased input costs from escalated tariffs on key pharmaceutical ingredients have motivated companies to diversify sourcing partners, explore alternative supplier agreements, and consider establishing or expanding domestic production. While these strategies can mitigate risks and support price stability, they also require significant investment and regulatory oversight to maintain product integrity. Distribution partners are adjusting pricing structures in response, affecting adoption rates and market accessibility for pet owners. Industry responses include vertical integration, cost-sharing alliances, and supply chain reconfiguration to strengthen market resilience.

Methodology & Data Sources

The study uses a hybrid research approach, combining qualitative interviews with industry stakeholders and veterinarians with secondary research from peer-reviewed journals, regulatory filings, and government publications. Comparative geographic assessments, scenario modeling, and thematic coding support a balanced and comprehensive analysis of market dynamics and strategic priorities.

Why This Report Matters

  • Targeted for senior decision-makers, this report equips organizations with actionable insights to navigate regulatory shifts, evolving stakeholder demands, and emerging threats in pets anti-infective therapeutics.
  • Strategic guidance is offered across R&D, manufacturing, distribution, and regional market entry, facilitating responsible innovation, operational agility, and new business opportunities.
  • The segmented analysis, technology evaluations, and regional forecasts help optimize portfolio management and align investment with areas of unmet clinical need.

Conclusion

Decision-makers will find this report invaluable for anticipating critical shifts, shaping strategy, and guiding successful product innovation in the global pets anti-infective therapeutics landscape. The full report provides granular, actionable guidance to support stakeholder objectives in a rapidly evolving market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing prevalence of antimicrobial resistance in companion animals driving demand for novel anti-infective therapies
5.2. Expansion of long acting injectable antibiotics enhancing compliance in canine and feline patients
5.3. Emergence of targeted bacteriophage therapies for treatment of multidrug resistant pet infections
5.4. Growing adoption of diagnostic led antimicrobial stewardship programs in veterinary practices
5.5. Integration of telemedicine platforms for remote monitoring and prescription of pet anti infective drugs
5.6. Rising investments in research of plant derived and peptide based antimicrobials for companion animals
5.7. Regulatory harmonization and expedited approvals boosting availability of generic veterinary antibiotics
5.8. Development of broad spectrum anti infective vaccines reducing incidence of common pet bacterial diseases
5.9. Surge in personalized antimicrobial susceptibility testing guiding precision treatment plans for pets
5.10. Strategic partnerships between biotech startups and veterinary pharma firms accelerating novel pet drug pipelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pets Anti-infective Drugs Market, by Drug Class
8.1. Introduction
8.2. Antibiotics
8.2.1. Aminoglycosides
8.2.2. Beta-Lactams
8.2.3. Macrolides
8.2.4. Tetracyclines
8.3. Antifungals
8.3.1. Azoles
8.3.2. Polyenes
8.4. Antiparasitics
8.4.1. Anticoccidials
8.4.2. Endectocides
8.5. Antivirals
8.5.1. Nucleoside Analogues
9. Pets Anti-infective Drugs Market, by Animal Type
9.1. Introduction
9.2. Cats
9.3. Dogs
9.4. Horses
9.5. Small Mammals
9.5.1. Rabbits
9.5.2. Rodents
10. Pets Anti-infective Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Online Retailers
10.3. Retail Pharmacies
10.4. Veterinary Hospitals
10.5. Veterinary Pharmacies
11. Pets Anti-infective Drugs Market, by Route of Administration
11.1. Introduction
11.2. Oral
11.3. Parenteral
11.3.1. Intramuscular
11.3.2. Intravenous
11.3.3. Subcutaneous
11.4. Topical
12. Americas Pets Anti-infective Drugs Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pets Anti-infective Drugs Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pets Anti-infective Drugs Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc.
15.3.2. Merck & Co., Inc.
15.3.3. Elanco Animal Health Incorporated
15.3.4. Boehringer Ingelheim Animal Health GmbH
15.3.5. Ceva Santé Animale SA
15.3.6. Virbac SA
15.3.7. Vetoquinol SA
15.3.8. Phibro Animal Health Corporation
15.3.9. Dechra Pharmaceuticals PLC
15.3.10. Neogen Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PETS ANTI-INFECTIVE DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PETS ANTI-INFECTIVE DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PETS ANTI-INFECTIVE DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PETS ANTI-INFECTIVE DRUGS MARKET: RESEARCHAI
FIGURE 24. PETS ANTI-INFECTIVE DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 25. PETS ANTI-INFECTIVE DRUGS MARKET: RESEARCHCONTACTS
FIGURE 26. PETS ANTI-INFECTIVE DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PETS ANTI-INFECTIVE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY BETA-LACTAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY BETA-LACTAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY AZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY AZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY POLYENES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY POLYENES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTICOCCIDIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTICOCCIDIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY NUCLEOSIDE ANALOGUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY NUCLEOSIDE ANALOGUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY CATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DOGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY HORSES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY HORSES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RABBITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RABBITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RODENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RODENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY VETERINARY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY VETERINARY PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 132. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 133. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 134. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 135. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 136. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 137. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 138. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 139. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 140. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 141. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 144. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 145. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 150. CANADA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 151. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 170. MEXICO PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 253. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 254. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 255. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 256. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 257. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 258. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 262. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 263. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 264. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 265. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 272. GERMANY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 273. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 274. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 275. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 276. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 277. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 278. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 279. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 282. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 283. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 284. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 285. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 286. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 287. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 292. FRANCE PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY SMALL MAMMALS, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 313. ITALY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 314. ITALY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 315. ITALY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 316. ITALY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 317. ITALY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 318. ITALY PETS ANTI-INFECTIVE DRUGS MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 319. ITALY PETS ANTI-INFECTIVE DRUGS MARKET SI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pets Anti-infective Drugs market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim Animal Health GmbH
  • Ceva Santé Animale SA
  • Virbac SA
  • Vetoquinol SA
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • Neogen Corporation

Related Topics

Related Reports

Anti-Infective Agents for Pets Market - Global Forecast 2025-2030 - Product Image

Anti-Infective Agents for Pets Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From
Anti-infectives Market - Global Forecast 2025-2032 - Product Image

Anti-infectives Market - Global Forecast 2025-2032

  • Report
  • 181 Pages
  • Global
From
Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2025-2033 - Product Image

Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2025-2033

  • Report
  • 136 Pages
  • Global
From
Anti-Infectives - Global Strategic Business Report - Product Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • 116 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.